GlassScriptPhysician profile
Scott K Douglas
NPI 1659318194
$1,532.62
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $149 · 2021: $414.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $199.20 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $161.14 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $137.59 | 2019-2020 | |
| Glaxosmithkline, LLC. | $133.57 | 2019-2021 | |
| Pfizer INC. | $132.00 | 2019 | |
| Lilly USA, LLC | $128.76 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.26 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $69.21 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $59.88 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $59.49 | 2019-2021 | |
| Astellas Pharma US INC | $53.53 | 2019-2021 | |
| Amgen INC. | $51.32 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $50.97 | 2019-2021 | |
| Allergan, INC. | $46.42 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.54 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.14 | 2019-2020 | |
| Abbott Laboratories | $25.73 | 2021 | |
| Amarin Pharma, INC. | $22.60 | 2019 | |
| Upsher-Smith Laboratories LLC | $18.79 | 2019 | |
| Senseonics, Incorporated | $18.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.32 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.